Comments
The United States Food and Drug Administration (US FDA) has approved a Formulation manufacturing facility of Eugia Pharma Specialities Ltd., a wholly owned subsidiary of Aurobindo Pharma.
The US regulator inspected Unit I, a Formulation manufacturing facility of Eugia Pharma Specialities situated at Koltur Village, Shameerpet, Medchal District, Telangana, from July 17-26, 2023.
Also read: Eugia Pharma receives USFDA approval for Plerixafor injection
“The inspection closed with zero observations and a classification of No Action Indicated (NAI),” Hyderabad-based Aurobindo said in a release.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.